Pivot Bio Gets $70M, Led by Bill Gates’s Fund, to Replace Fertilizer

Pivot Bio Gets $70M, Led by Bill Gates’s Fund, to Replace Fertilizer

Pivot’s microbial technology will allow farmers to reduce the use of fertilizers, which can generate potent greenhouse gases.

BriaCell Announces Positive Phase IIa Data in Advanced Breast Cancer

BriaCell Announces Positive Phase IIa Data in Advanced Breast Cancer

To further investigate anti-tumor activity, Briacell will explore combination therapies.

Principia Biopharma announces $100M IPO

Principia Biopharma announces $100M IPO

Principia is a spinoff from Jack Taunton’s lab at UCSF.

Atreca Raises $125 Million

Atreca Raises $125 Million

Atreca was one of the first companies in Mission Bay Capital’s portfolio.

FDA Grants Breakthrough Therapy Designation for Concentric Analgesics’ CA-008 in Post-Surgical Pain

FDA Grants Breakthrough Therapy Designation for Concentric Analgesics’ CA-008 in Post-Surgical Pain

The drug is an alternative to opiates.

Synvitrobio rebrands & raises cash

Synvitrobio rebrands & raises cash

Under its new name, Tierra Biosciences, the company will focus on agricultural and biochemical products.

Newomics Closes $3.9M Series A Round

Newomics Closes $3.9M Series A Round

Newomics will use the funds to expand the team and commercialize its silicon-based multinozzle emitter array technology.

Pivot Bio aims to stem red tides

Pivot Bio aims to stem red tides

Pivot’s crop probiotics prevent the nitrate runoff that causes algal blight in waterways.

WuXi AppTec and Cyclica team to drive polypharmacology in drug discovery

WuXi AppTec and Cyclica team to drive polypharmacology in drug discovery

The collaboration will advance polypharmacology in drug discovery using AI-augmented technology.

Principia Biopharma files for an $86 million IPO

Principia Biopharma files for an $86 million IPO

Principia plans to list on the Nasdaq under the symbol PRNB.